Ambrus R B, Svendsen L B, Hillingsø J G, Hansen M L, Achiam M P
Department of Surgical Gastroenterology, Liver Transplantation Center, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
Department of Surgical Gastroenterology, Liver Transplantation Center, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Scand J Surg. 2015 Jun;104(2):86-91. doi: 10.1177/1457496914529274. Epub 2014 Apr 15.
Complications in the biliary tract occur in 5%-30% after liver transplantation and the main part of the complications is successfully managed with endoscopic retrograde cholangiopancreaticography (ERCP). The incidence and risk factors for post-ERCP complications in liver transplantation patients are not well described. Our objective was to define the frequency of post-ERCP complications in liver transplantation patients at the Abdominal Center, Rigshospitalet, the only Liver Transplantation Center in Denmark.
Retrospective study of all ERCPs performed in liver transplantation patients during a 9-year period.
A total of 292 ERCPs were included. Overall post-ERCP complications occurred in 24 procedures (8.2%): pancreatitis in 8 (2.7%), bleeding in 5 (1.7%), and cholangitis in 13 (4.5%) procedures. Simultaneous pancreatitis and cholangitis, and simultaneous bleeding and cholangitis occurred after two procedures, respectively. Multivariate analysis concerning overall complications identified biliary sphincterotomy (p = 0.006) and time since liver transplantation within 90 days postoperatively (p = 0.044) as risk factors for post-ERCP complications. Specifically concerning post-ERCP pancreatitis (PEP), it was found that pre-ERCP cholangitis was another independent risk factor for PEP (p = 0.026). Stent in the biliary tract prior to ERCP seemed to be protective (p = 0.041).
Complications were of surprisingly mild degree. The rates of post-ERCP complications in our study were in line with previous studies with liver transplantation patients. Cholangitis prior to ERCP may be another risk factor for post-ERCP pancreatitis.
肝移植术后胆道并发症的发生率为5%-30%,内镜逆行胰胆管造影术(ERCP)成功处理了大部分此类并发症。肝移植患者ERCP术后并发症的发生率及危险因素尚未得到充分描述。我们的目的是确定丹麦唯一的肝移植中心——里格霍斯帕勒特腹部中心肝移植患者ERCP术后并发症的发生率。
对9年间肝移植患者进行的所有ERCP检查进行回顾性研究。
共纳入292例ERCP检查。总体ERCP术后并发症发生在24例(8.2%):胰腺炎8例(2.7%),出血5例(1.7%),胆管炎13例(4.5%)。分别有2例术后同时发生胰腺炎和胆管炎,2例同时发生出血和胆管炎。关于总体并发症的多因素分析确定胆管括约肌切开术(p = 0.006)和肝移植术后90天内的时间(p = 0.044)为ERCP术后并发症的危险因素。具体而言,关于ERCP术后胰腺炎(PEP),发现ERCP术前胆管炎是PEP的另一个独立危险因素(p = 0.026)。ERCP术前胆道支架似乎具有保护作用(p = 0.041)。
并发症程度出人意料地轻微。我们研究中ERCP术后并发症的发生率与之前肝移植患者的研究结果一致。ERCP术前胆管炎可能是ERCP术后胰腺炎(PEP)的另一个危险因素。